Dermata Therapeutics, Inc. — Director's Dealing 2021

Nov 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dermata Therapeutics, Inc. (DRMA)
CIK: 0001853816
Period of Report: 2021-11-23

Reporting Person: PROEHL GERALD T (Director, President, CEO and Chairman, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-23	Common Stock	P	20000	$2.40	Acquired	59512	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	17857	Indirect
Common Stock	8928	Indirect
Common Stock	35767	Indirect
Common Stock	2905544	Indirect
Common Stock	152857	Indirect

Footnotes

F1: Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.